(Nasdaq: HOLX), a leading medical technology company dedicated to improving women's health, today announced new data that ...
FLAMeS, a new convolutional neural network, enhances MS lesion segmentation accuracy using only T2-weighted FLAIR images, ...
MedPage Today on MSN
Novel Pills Promising in Relapsed/Refractory Multiple Myeloma
Iberdomide and mezigdomide are currently being evaluated for the treatment of patients with multiple myeloma in a number of ...
Detailed price information for Crane Harbor Acquisition Corp. Cl A (CHAC-Q) from The Globe and Mail including charting and trades.
The authors provide a useful integrated analytical approach to investigating MASLD focused on diverse multiomic integration methods. The strength of evidence for this new resource is solid, as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback